PFMD Board
PFMD has from inception been formed as an equal collaboration among its members which includes patient groups, patients, the pharmaceutical industry and regulators. The leadership and governance model adopted by PFMD ensures at least equal or greater share of voice for patient groups. PFMD activities are funded and supported by member organisations.
Nicola Bedlington
Secretary General, European Patients Forum
Veronica Todaro
Vice President, National Programs, Parkinson’s Disease Foundation
Graeme Johnston
Patient Advocate, Individual/ Patient
Alexandra Moutet
Global Head of Patient Affairs, UCB
